Mitomycin C.
Copyright policy )Mitomycin C.
In conclusion, recent work has highlighted the fact that NSCLCs have elevated levels of NQO1 activity and that such an increase represents an excellent target for therapeutic exploitation. The 5-year survival rate seen with lung cancer is dismal and there is a high number of cancer deaths associated with this disease each year. This renders the design of molecules that can be activated by NQO1 (such as MeDZQ or CB 10-200) an extremely important and urgent issue.
Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Drug Design, Mitomycin, NAD(P)H Dehydrogenase (Quinone), Quinones, Humans, Oxidation-Reduction, Substrate Specificity
Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Drug Design, Mitomycin, NAD(P)H Dehydrogenase (Quinone), Quinones, Humans, Oxidation-Reduction, Substrate Specificity
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!